We would love to hear your thoughts about our site and services, please take our survey here.
It would appear that Fortacin was approved in Singapore on the 5th July 2022, was this covered before?
Yes and this was released on 17 April 2023…….
Can’t be long until we get an update….
Jamie Gibson, CEO of the Group, said, “We are delighted with the highly significant and positive
results from the Phase 3 clinical study in China, which reinforces the results from the European
and US Phase 3 clinical studies. This represents an important milestone in the regulatory
submission process in China. We now look forward to our commercial partner in China submitting the New Drug Application (“NDA”) to National Medical Products Administration (“NMPA”) by the
end of Q3 2023 with approval expected 12 months later.”
Jamie Gibson further added, “Senstend has the potential to help about 9 million patients in
China during its first year of launch, growing to over 170 million by the tenth year. Our strong
partner Wanbang Biopharmaceutical, who benefits from being part of the Fosun network. This
company has the marketing expertise established e-commerce platforms and an unrivalled
nationwide logic and distribution through Sinopharm, China’s number one pharmaceutical and healthcare distributor, through its network of hospitals, clinics and pharmacies to ensure the
commercial success of Senstend in China.
Sent email to Jamie and Dr Mike a number of weeks ago and no response. They would always respond before.
Https://markets.ft.com/data/equities/tearsheet/forecasts?s=DEMG:LSE
Https://www.auajournals.org/doi/epdf/10.1097/JU.0000000000003291.05
Https://www.auajournals.org/doi/10.1097/JU.0000000000003291.05
Share price forecast
The one analyst offering a 12 month price target expects Deltex Medical Group plc share price to rise to 8.00 in the next year from the last price of 0.145.
An upturn of the SP would be most welcome and this needs China to be approved as this would help us significantly. US then needs to come good!!!!
2025 is the year…..
Share price forecast
The one analyst offering a 12 month price target expects Deltex Medical Group plc share price to rise to 8.00 in the next year from the last price of 0.145.
My last message from him was.
Regent will one day be a good investment I hope.
I do think Jim Mellon will continue to back Regent Pacific as he has put in millions not to get a return.
And that is not where I started off at!!! A few years before then and we all know where we were then.
China is our best hope for now and maybe US in a year or two!
I emailed Jamie twice recently but nothing back.
I was really here for the US approval.
China might now be my best hope of getting my money back.
So a long way back for me….. if ever.
The 1:20 consolidation kill me.
On the 31st January 2019 with RP at 3.07p my holding was worth 160,000
On the 31st January 2024 with RP at 5.07
my holding was worth 14,000
Madness